Event

Bookmark and Share

This article is in the news archive.

Webinar | Advances in cellular reprogramming: from stem cells to printed tissues

c81bbf53-2652-42d5-a8b0-ccd2953d05a5.png
THE CELL CODING COMPANY

Webinar

 

Advances in cellular reprogramming: 

from stem cells to printed tissues








Prof Hagan Bayley & Dr Mark Kotter 

Date: 29th June 2020
Time: 4pm GMT | 8am PST | 11am EST
Duration: 60 minutes


 

Register for our latest free-to-attend webinar!

REGISTER NOW


 
0373a12c-1627-496e-94d0-ca835aadae8a.png

A scalable technology platform capable of producing consistent batches of every human cell has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease.



In this webinar, you will learn 
 
d6f02d11-2a31-4241-b962-15453542a6c9.png

Today’s challenges in CNS research, disease modelling and drug discovery: limited access to reliable human models

d6f02d11-2a31-4241-b962-15453542a6c9.png

How a novel cellular reprogramming technology, opti-ox, resolves the inconsistency of cellular reprogramming and enables the precise, consistent, and scalable production of human cells

d6f02d11-2a31-4241-b962-15453542a6c9.png

The fabrication of synthetic, printed and hybrid materials, and their applications

0373a12c-1627-496e-94d0-ca835aadae8a.png

About the speakers 



 
Prof Hagan Bayley | University of Oxford

 

Hagan Bayley is the Professor of Chemical Biology at the University of Oxford. A major interest of his laboratory is the development of engineered protein nanopores for stochastic detection. In 2005, Professor Bayley founded Oxford Nanopore, which has manufactured the MinION portable DNA sequencer. Recently, the Bayley lab has developed techniques for the fabrication of 3D tissues, both living and synthetic. Professor Bayley is currently a co-Director of the Oxford Martin School programme on 3D Printing for Brain Repair. 
http://bayley.chem.ox.ac.uk/

 
 





Dr Mark Kotter | Founder & CEO Bit Bio

 

By combining synthetic and Stem Cell Biology, his team has developed a benchmark technology for the efficient and consistent production of human cells for use in research, drug development, and cell therapy. He is the founder of Bit Bio and co-founder of the cultured meat startup Meatable. 

0373a12c-1627-496e-94d0-ca835aadae8a.png
Register for the webinar and Q&A with our expert speakers
c81bbf53-2652-42d5-a8b0-ccd2953d05a5.png
57889dfe-d165-44f1-954e-cbafb96fc810.png 64d463ee-b28a-4a98-90cc-4654b5927a2f.png
Copyright © 2020 Bit Bio Ltd. - The Cell Coding Company
Discovery Drive, Cambridge Biomedical Campus,
Cambridge, CB2 0AX, UK

Posted on 26/06/2020

Further events

Go to the events index page.